Jason Micklefield
Papers
1
Total Citations
53
H-Index
1
About
Jason Micklefield is a leading figure in chemical biology and synthetic biology, renowned for pioneering strategies to engineer natural product biosynthesis. His research focuses on the rational design and reprogramming of biosynthetic pathways, particularly for polyketides and non-ribosomal peptides—classes of complex natural products that include many clinically vital antibiotics and anticancer agents. Micklefield’s major contributions include developing plug-and-play platforms for combinatorial biosynthesis, enabling the heterologous production of aromatic polyketides in Escherichia coli, as demonstrated in his highly cited 2019 work (53 citations). This breakthrough allows for the systematic mixing and matching of biosynthetic modules to generate novel chemical diversity. His work has profoundly impacted the field by providing tools to access and modify these structurally intricate molecules, addressing the urgent need for new drug leads. With hundreds of citations across his portfolio, Micklefield’s achievements include elucidating mechanisms of enzyme catalysis and substrate specificity, and his research continues to inspire the next generation of synthetic biologists and medicinal chemists in the quest to replenish the clinical pipeline.
Research Focus
Key Achievements
Top Papers
- 1